Scleromyxoedema due to a plasma cell neoplasm: rapid remission with bortezomib, thalidomide and dexamethasone
Syndrome of inappropriate antidiuretic hormone secretion associated with primary cutaneous anaplastic large cell lymphoma
Allogeneic Stem Cell Transplantation for Myelofibrosis in 2012
Janus kinase Inhibition and its effect upon the therapeutic landscape for myelofibrosis: from palliation to cure?
Chemoimmunotherapy with ofatumumab in combination with CHOP in previously untreated follicular lymphoma
BCR-ABL1 tyrosine kinase sustained MECOM expression in chronic myeloid leukaemia
Increased incidence of chronic lymphocytic leukaemia and lymphomas in patients with Merkel cell carcinoma – a population based study of 335 cases with neuroendocrine skin tumour
Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trial
Increased prevalence of light chain monoclonal gammopathy of undetermined significance (LC-MGUS) in first-degree relatives of individuals with multiple myeloma
Genome-wide analysis of cytogenetic aberrations in ETV6/RUNX1 -positive childhood acute lymphoblastic leukaemia
Ponatinib may overcome resistance of FLT3-ITD harbouring additional point mutations, notably the previously refractory F691I mutation
The withdrawal of Activated Protein C from the use in patients with severe sepsis and DIC [Amendment to the BCSH guideline on disseminated intravascular coagulation],
Re-infused lymphocyte dose does not influence disease control following upfront autologous stem cell transplantation for multiple myeloma
Efficacy of bortezomib, lenalidomide and dexamethasone (VRD) in secondary plasma cell leukaemia
Coeliac disease and risk of venous thromboembolism: a nationwide population-based case-control study
The use of ADAMTS13 activity, platelet count, and serum creatinine to differentiate acquired thrombotic thrombocytopenic purpura from other thrombotic microangiopathies
Deletion of chromosome 20 in bone marrow of patients with Shwachman-Diamond syndrome, loss of the EIF6 gene and benign prognosis
Safety of deferasirox in sickle cell disease patients with co-existing liver impairment
Safety of deferasirox in sickle cell disease patients with co-existing liver impairment – response to Sinakos et al
Imatinib resistant BCR - ABL1 mutations at relapse in children with Ph+ALL: a Children's Oncology Group (COG) study
MCL1 down-regulation plays a critical role in mediating the higher anti-leukaemic activity of the multi-kinase inhibitor Sorafenib with respect to Dasatinib
The homozygous mutation G75R in the human SLC11A2 gene leads to microcytic anaemia and iron overload